Echelon Wealth Partners reaffirmed their buy rating on shares of Columbia Care (OTCMKTS:CCHWF) in a research report report published on Wednesday morning, Anlyst Ratings reports. Echelon Wealth Partners currently has a $13.00 price objective on the stock.
Several other analysts also recently weighed in on the company. Cantor Fitzgerald began coverage on Columbia Care in a research report on Friday, January 8th. They set a neutral rating and a $7.30 target price for the company. Alliance Global Partners reiterated a buy rating on shares of Columbia Care in a research report on Wednesday, December 23rd. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock has an average rating of Buy and a consensus target price of $11.10.
OTCMKTS:CCHWF opened at $6.54 on Wednesday. Columbia Care has a twelve month low of $0.78 and a twelve month high of $7.07. The stock has a fifty day simple moving average of $5.24 and a 200-day simple moving average of $3.89.
Columbia Care Inc cultivates, manufactures, and provides medical and adult use cannabis products and related services. The company holds licenses in 18 jurisdictions in the United States and the European Union. It operates a medical cannabis dispensary in New Jersey. The company was founded in 2012 and is headquartered in New York, New York.
Featured Article: What does it mean to hold a stock in street name?
Receive News & Ratings for Columbia Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Care and related companies with MarketBeat.com's FREE daily email newsletter.